LOW-DOSE ORAL WEEKLY METHOTREXATE (MTX) SIGNIFICANTLY REDUCES THE FREQUENCY OF PROGRESSION OF IMPAIRMENT IN PATIENTS WITH CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS (CPMS)

Authors
GOODKIN DE RUDICK RA MEDENDORP SV DAUGHTRY MM SCHWETZ K
Citation
De. Goodkin et al., LOW-DOSE ORAL WEEKLY METHOTREXATE (MTX) SIGNIFICANTLY REDUCES THE FREQUENCY OF PROGRESSION OF IMPAIRMENT IN PATIENTS WITH CHRONIC PROGRESSIVE MULTIPLE-SCLEROSIS (CPMS), Neurology, 44(4), 1994, pp. 10000357-10000357
Citations number
1
Categorie Soggetti
Clinical Neurology
Journal title
Neurology → ACNP
ISSN journal
00283878
Volume
44
Issue
4
Year of publication
1994
Supplement
2
Pages
10000357 - 10000357
Database
ISI
SICI code
0028-3878(1994)44:4<10000357:LOWM(S>2.0.ZU;2-P